Bradmer Pharmaceuticals Inc.: Director Resignation
2013年8月1日 - 6:00AM
Marketwired Canada
Bradmer Pharmaceuticals Inc. (the "Corporation") (TSX VENTURE:BMR.H) announced
today that Perry N. Dellelce has resigned as a director of the Corporation. He
will continue to act as a consultant to the Corporation. The Corporation thanks
Mr. Dellelce for his commitment and significant past contribution to the
Corporation.
NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION PROVIDER (AS THAT TERM IS
DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR
THE ADEQUACY OR ACCURACY OF THIS RELEASE.
FOR FURTHER INFORMATION PLEASE CONTACT:
Bradmer Pharmaceuticals Inc.
Paul Van Damme
Chief Financial Officer
416.847.6905
Bradmer Pharmaceuticals (TSXV:BMR.H)
過去 株価チャート
から 5 2024 まで 6 2024
Bradmer Pharmaceuticals (TSXV:BMR.H)
過去 株価チャート
から 6 2023 まで 6 2024
Real-Time news about Bradmer Pharmaceuticals (トロントベンチャー取引所): 0 recent articles
その他のBradmer Pharmaceuticals Inc.ニュース記事